News brief­ing: Boehringer In­gel­heim ex­pands pro­tein degra­da­tion ef­forts; Pfiz­er en­lists a new AI part­ner

Boehringer In­gel­heim is ex­pand­ing its ef­forts in pro­tein degra­da­tion, sign­ing a pact with the Aus­tri­an biotech Prox­y­gen to de­vel­op a tech­nol­o­gy known as “mol­e­c­u­lar glue …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.